<?xml version="1.0" encoding="utf-8"?>
<rss version="2.0">
  <channel>
    <title>Featured Headlines Feed for CBLI</title>
    <link />
    <description>Headlines for CLEVELAND BIOLABS, INC.</description>
    <docs>http://www.rssboard.org/rss-specification</docs>
    <generator>Argotic Syndication Framework 2008.0.2.0, http://www.codeplex.com/Argotic</generator>
    <item>
      <title>Profiting From BARDA Contract Awards</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1453961-profiting-from-barda-contract-awards.aspx</link>
      <author>Seeking Alpha</author>
      <pubDate>Wed, 22 May 2013 13:33:43 GMT</pubDate>
    </item>
    <item>
      <title>Cleveland BioLabs' CEO Discusses Q1 2013 Results - Earnings Call Transcript</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1421291-cleveland-biolabs-ceo-discusses-q1-2013-results-earnings-call-transcript.aspx</link>
      <author>Seeking Alpha</author>
      <pubDate>Thu, 09 May 2013 17:11:02 GMT</pubDate>
    </item>
    <item>
      <title>Isis Initiates ISIS-STAT3 Study - Analyst Blog</title>
      <link>http://www.fool.com/news/xt/zacks/www.zacks.com/stock/news/98882/isis-initiates-isis-stat3-study.aspx</link>
      <author>Zacks</author>
      <pubDate>Tue, 07 May 2013 17:46:01 GMT</pubDate>
    </item>
    <item>
      <title>Negative Opinion on AVEO/ALPMY Candidate - Analyst Blog</title>
      <link>http://www.fool.com/news/xt/zacks/www.zacks.com/stock/news/98645/negative-opinion-on-aveo-alpmy-candidate.aspx</link>
      <author>Zacks</author>
      <pubDate>Fri, 03 May 2013 17:00:01 GMT</pubDate>
    </item>
    <item>
      <title>Loss at Aegerion Narrower Than Expected - Analyst Blog</title>
      <link>http://www.fool.com/news/xt/zacks/www.zacks.com/stock/news/98642/loss-at-aegerion-narrower-than-expected.aspx</link>
      <author>Zacks</author>
      <pubDate>Fri, 03 May 2013 16:30:01 GMT</pubDate>
    </item>
    <item>
      <title>Affymetrix Reports Disappointing 1Q - Analyst Blog</title>
      <link>http://www.fool.com/news/xt/zacks/www.zacks.com/stock/news/98411/affymetrix-reports-disappointing-1q.aspx</link>
      <author>Zacks</author>
      <pubDate>Thu, 02 May 2013 07:49:01 GMT</pubDate>
    </item>
    <item>
      <title>Vertex Loss Lower, Kalydeco Outlook Up - Analyst Blog</title>
      <link>http://www.fool.com/news/xt/zacks/www.zacks.com/stock/news/98330/vertex-loss-lower-kalydeco-outlook-up.aspx</link>
      <author>Zacks</author>
      <pubDate>Wed, 01 May 2013 08:52:01 GMT</pubDate>
    </item>
    <item>
      <title>Double Setback for Gilead - Analyst Blog</title>
      <link>http://www.fool.com/news/xt/zacks/www.zacks.com/stock/news/98290/double-setback-for-gilead.aspx</link>
      <author>Zacks</author>
      <pubDate>Tue, 30 Apr 2013 15:50:01 GMT</pubDate>
    </item>
    <item>
      <title>Merck - Pfizer in Diabetes Deal - Analyst Blog</title>
      <link>http://www.fool.com/news/xt/zacks/www.zacks.com/stock/news/98285/merck-pfizer-in-diabetes-deal.aspx</link>
      <author>Zacks</author>
      <pubDate>Tue, 30 Apr 2013 15:00:01 GMT</pubDate>
    </item>
    <item>
      <title>CHMP in Favor of Celgene's Revlimid - Analyst Blog</title>
      <link>http://www.fool.com/news/xt/zacks/www.zacks.com/stock/news/98184/chmp-in-favor-of-celgenes-revlimid.aspx</link>
      <author>Zacks</author>
      <pubDate>Mon, 29 Apr 2013 16:40:01 GMT</pubDate>
    </item>
    <item>
      <title>Geron Narrows Loss; Cuts Jobs - Analyst Blog</title>
      <link>http://www.fool.com/news/xt/zacks/www.zacks.com/stock/news/98128/geron-narrows-loss-cuts-jobs.aspx</link>
      <author>Zacks</author>
      <pubDate>Mon, 29 Apr 2013 09:50:01 GMT</pubDate>
    </item>
    <item>
      <title>Earnings Increase at The Medicines Co. - Analyst Blog</title>
      <link>http://www.fool.com/news/xt/zacks/www.zacks.com/stock/news/98088/earnings-increase-at-the-medicines-co.aspx</link>
      <author>Zacks</author>
      <pubDate>Fri, 26 Apr 2013 16:30:01 GMT</pubDate>
    </item>
    <item>
      <title>Biogen's Earnings Surpass Expectations - Analyst Blog</title>
      <link>http://www.fool.com/news/xt/zacks/www.zacks.com/stock/news/97892/biogens-earnings-surpass-expectations.aspx</link>
      <author>Zacks</author>
      <pubDate>Thu, 25 Apr 2013 11:30:01 GMT</pubDate>
    </item>
    <item>
      <title>Celgene Earnings Rise Y/Y - Analyst Blog</title>
      <link>http://www.fool.com/news/xt/zacks/www.zacks.com/stock/news/97900/celgene-earnings-rise-y-y.aspx</link>
      <author>Zacks</author>
      <pubDate>Thu, 25 Apr 2013 10:57:01 GMT</pubDate>
    </item>
    <item>
      <title>Isis Pharma's ISIS-SMNRx Progresses - Analyst Blog</title>
      <link>http://www.fool.com/news/xt/zacks/www.zacks.com/stock/news/97839/isis-pharmas-isis-smnrx-progresses.aspx</link>
      <author>Zacks</author>
      <pubDate>Wed, 24 Apr 2013 17:10:01 GMT</pubDate>
    </item>
    <item>
      <title>Tax Benefit Boosts Amgen Earnings  - Analyst Blog</title>
      <link>http://www.fool.com/news/xt/zacks/www.zacks.com/stock/news/97804/tax-benefit-boosts-amgen-earnings.aspx</link>
      <author>Zacks</author>
      <pubDate>Wed, 24 Apr 2013 11:56:01 GMT</pubDate>
    </item>
    <item>
      <title>Merck - BMY in HCV Deal  - Analyst Blog</title>
      <link>http://www.fool.com/news/xt/zacks/www.zacks.com/stock/news/97734/merck-bmy-in-hcv-deal.aspx</link>
      <author>Zacks</author>
      <pubDate>Tue, 23 Apr 2013 18:10:01 GMT</pubDate>
    </item>
    <item>
      <title>Cleveland BioLabs Offers Medical Countermeasures Against Potential Terrorist Attacks</title>
      <link>http://www.fool.com/news/xt/trefis/www.trefis.com/stock/cbli/articles/181935/cleveland-biolabs-offers-medical-countermeasures-against-potential-terrorist-attacks-3/2013-04-23.aspx</link>
      <author>Trefis</author>
      <pubDate>Tue, 23 Apr 2013 09:42:00 GMT</pubDate>
    </item>
    <item>
      <title>Cleveland BioLabs Offers Medical Countermeasures Against Potential Terrorist Attacks</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1359931-cleveland-biolabs-offers-medical-countermeasures-against-potential-terrorist-attacks.aspx</link>
      <author>Seeking Alpha</author>
      <pubDate>Tue, 23 Apr 2013 09:31:00 GMT</pubDate>
    </item>
    <item>
      <title>Merck In-Licenses from Xenon  - Analyst Blog</title>
      <link>http://www.fool.com/news/xt/zacks/www.zacks.com/stock/news/97618/merck-in-licenses-from-xenon.aspx</link>
      <author>Zacks</author>
      <pubDate>Mon, 22 Apr 2013 17:50:01 GMT</pubDate>
    </item>
  </channel>
</rss>
